A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix

Histology and Histopathology

Volumn 22, Issue 4-6, 2007, Pages 587-592

  Carreras, R ^a   Alameda, F ^a,b   Mancebo, G ^a   Garcia Moreno P ^a   Marinoso M L M ^a   Costa, C ^a   Fuste P ^a   Baro T ^a   Serrano, S ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Cervix; CIN; Cyclin D1; Ki 67 LI; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER RISK; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU;

ANTIGENS, CD1; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN D1; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; PAPILLOMAVIRUS INFECTIONS; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 34247543060     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alameda F., Fuste P., Boluda S., Ferrer L., Baro T., Marinoso L., Mancebo G., Carreras R. and Serrano S. (2004). The Ki67 labeling Index is not a useful predictor for the follow up of cervical Intraepithelial Neoplasia-1. J. Low Gen. Tract Dis. 8, 313-316.
2. Bae D.S., Cho S.B., Kim Y.J., Whang J.D., Song S.Y., Park C.S., Kim D.S. and Lee J.H. (2001). Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol. Oncol. 81, 341-347.
3. Baldin V., Lukas J., Marcote M.J., Pagano M. and Draetta G. (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
4. Brumm C., Riviere A., Wilckens C. and Loning T. (1990). Inmunohistochemical investigation andnorthern blot analysis of c-erbB2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri. Virchows Arch (A). 417, 477-484.
5. Chang J.L., Tsao Y.P., Liu D.W., Han C.P., Lee W.H. and Chen S.L. (1999). The exprssion of type I growth factor receptors in squamous neoplastic changes of the uterine cervix. Gynecol. Oncol. 73, 62-71.
6. Cheung T.H., Yu M.M., Lo K.W., Yim S.F., Chung T.K. and Wong Y.F. (2001). Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett. 166, 199-206.
7. Cho N.H, Kim Y.T. and Kim J.W. (1997). Correlation between G1 cyclins and HPV in the uterine cervix. Int. J. Gynecol. Pathol. 16, 339-347.
8. Cho N.H., Kim Y.T. and Kim J.W. (2002). Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors. Yonsei Med. J. 43, 722-728.
9. Crish J.F., Bone F., Balasubramanian S., Zaim T.M., Wagner T., Yun J., Rorke E.A. and Eckert R.L. (2000). Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermis alters expression of cell cycle regulatory proteins. Carcinogenesis 21, 1031-1037.
10. Diehl J.A., Zindy F. and Sherr C.J. (1997a). Inhibition of cyclin D1 phosphorylation on threonine286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Gen. Dev. 11, 957-72.
11. Diehl J.A., Zindy F. and Sherr C.J. (1997b). A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin Dependent-kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell Biol. 17, 7362-7374.
12. Gerdes H., Lemke H., Baisch H., Wacker H.H., Schwab U. and Stein H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710-1715.
13. Kedzia W., Schmidt M., Frankowski A. and Spaczynski M. (2002). Immunohistochemical assay of p53, cyclin D1, c-erb-b2, EGFR and Ki-67 proteins HPV positive and HPV negative cervical cancers. Folia Histochem. Cytobiol. 40, 37-41.
14. Kim Y.T. and Zhao M. (2005). Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J. 46, 597-613.
15. Konishi I., Fujii S., Nonogaki H., Nanbu Y., Iwai T. and Mori T. (1991). Inmunohistochemical analysis of estrogen receptors, progesterone receptors, ki-67 antigen and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer 68, 1340-1350.
16. Maeda M.Y., Simoes M., Wakamatsu A., Longatto Filho A.L., Oyafuso M., de Mello E.S., Otta M.M. and Alves V.A. (2001). Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions. Pathologica 93, 189-195.
17. McCluggage W.G, Maxwell P. and Bharucha H. (1998). Inmunohistochemical detection of metallothionein and MIB-1 in uterine cervical squamous lesions. Int. J. Gynecol. Pathol. 17, 29-35.
18. Nichols G.E., Williams M.E., Gaffey M.J. and Stoler M.H. (1996). Cyclin D1 gene expression in human cervical neoplasia. Mod. Pathol. 9, 418-425.
19. Niibe Y., Nakano T., Ohno T., Suzuki Y., Oka K. and Tsujii H. (2003). Prognostic significance of c-erbB-2/Her2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int. J. Gynecol. Cancer 13, 849-855.
20. Payne S., Kernohan N.M. and Walker F. (1996). Proliferation in the normal cervix and preinvasive cervical lesions. J. Clin. Pathol. 49, 667-671.
21. Resnick M., Lester S., Tate J.E., Sheets E.E., Sparks C. and Crum C.P. (1996). Viral and histopathological correlates on MN and MIB-1 expression in cervical intra-epithelial neoplasia. Hum. Pathol. 27 234-239.
22. Robertson A.J., Anderson J.M., Beck J.S., Burnett R.A., Howatson S.R., Lee F.D., Lessells A.M., McLaren K.M., Moss S.M. and Simpson J.G. Observer variability in histological reporting of cervical biopsy specimens. J. Clin. Pathol. 42, 231-238.
23. Skomedal H., Kristensen G.B., Lie A.K. and Holm R. (1999). Aberrant expresión of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol. Oncol. 73, 223-228.
24. Southern S.A. and Herrington C.S. (1998). Differential cell cycle regulation by low-and high-risk human papillomavirus in low-grade squamous intraepithelial lesions of the cervix. Cancer Res. 58, 2941-2945.
25. Wright T.C., Kurman R.J. and Ferenczy A. (2002). Precancerous lesions of the cervix. Chap. 7. In Blaunstein's patholopgy of the female genital tract. Fifth Ed. Kurman R.J. (ed). Springer Verlag. NY. p 225.